Theralase Technologies Inc.

Public

Theralase Technologies Inc. is now publicly traded

The data on this page reflects Theralase Technologies Inc.'s private-market history up to the point it went public, including its funding rounds, valuation, and investors.

Last Round

Seed Round

Aug 31, 2026

Total Funding Raised

$181,378

Company Overview

Theralase Technologies Inc. is a pharmaceutical and medical device company that researches, develops, and commercializes light-activated photo dynamic compounds for cancer treatment and super-pulsed laser technology for pain management.

Sector

Healthcare

AI Layer

Non-AI

Keywords

therapeutic laserphotodynamic therapyPDTpain managementmedical lasercold laser therapycancer treatmentmusculoskeletal painbiofeedback technologylaser medicinedrug-device combinationnon-invasive treatmentclinical trialsbiotech

Theralase Technologies Inc. Comparables

Compare Theralase Technologies Inc. with similar companies based on industry and business-model similarity.

Theralase Technologies Inc. comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Enabled Therapeutics	69%
Prokarium	61%
Dr. I&B Co., Ltd.	57%

View all Comparables

Theralase Technologies Inc. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Seed Round	Aug 31, 2026
Private Placement	May 27, 2026

View all Funding Rounds

Theralase Technologies Inc. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Theralase Technologies Inc. Filings

SEC and related filings with document metadata.

Firmographic Details

HeadquartersCanada

Year Founded1994

Last FundingAug 31, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?